Judge Approves Bankruptcy Plan For Opioid-Maker Insys
The case was being closely observed because it could predict Purdue Pharma’s fate. News on the epidemic is also on Minnesota’s new efforts to treat overdoses and save lives.
The Wall Street Journal: Opioid-Maker Insys Wins Court Approval Of Bankruptcy Plan
Insys Therapeutics Inc., the first drugmaker driven to bankruptcy by fallout from the opioid crisis, won court approval of a bankruptcy plan that pays less than a dime for each dollar it owes to the people, cities, states and tribes claiming damage from the drug epidemic. Shareholders of the once-thriving company will be wiped out under the chapter 11 plan approved Thursday by Judge Kevin Gross in the U.S. Bankruptcy Court in Wilmington, Del. (Brickley, 1/16)
MPR News: Minneapolis Libraries, Grocery Stores Join Response To Opioid Overdoses With Training
The experience spurred Hennepin County officials to reassess what they could do as the opioid epidemic continued to claim tens of thousands of lives each year across the country. The county has since implemented a policy explaining how best to treat overdoses. They have also started training 60 county officers and 80 contract security officers on how to administer naloxone, also known by the brand name Narcan — a medication that can reverse an opioid overdose. (Collins, 1/16)
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.